Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Trauner

Showing results (681-690 of 777) with videos related to

Pageof 78
Sort By:
Journal of Hepatology|May 23, 2017
norUrsodeoxycholic acid improves cholestasis in primary sclerosing cholangitisPeter Fickert, Gideon M Hirschfield, Gerald Denk, et al.
Diabetes|July 14, 2018
miR-30a Remodels Subcutaneous Adipose Tissue Inflammation to Improve Insulin Sensitivity in ObesityEun-Hee Koh, Natasha Chernis, Pradip K Saha, et al.
Ultraschall in Der Medizin (Stuttgart, Germany : 1980)|August 7, 2025
UDFF and Auto pSWE accurately assess liver steatosis and fibrosis risk in obese patients with MASLDNina Dominik, Larissa Nixdorf, Michael Schwarz, et al.
Gut|October 11, 2018
Inhibition of monoacylglycerol lipase, an anti-inflammatory and antifibrogenic strategy in the liverAida Habib, Dina Chokr, JingHong Wan, et al.
JHEP Reports : Innovation in Hepatology|June 17, 2025
Minimal residual ascites 3 months after TIPS implantation implicates worse clinical outcomes in patients with cirrhosisJim Benjamin Mauz, Lukas Hartl, Andrea Kornfehl, et al.
Journal of Autoimmunity|February 23, 2021
Histone deacetylase 1 controls CD4<sup>+</sup> T cell trafficking in autoinflammatory diseasesPatricia Hamminger, Luca Marchetti, Teresa Preglej, et al.
Journal of Hepatology|December 21, 2016
The FXR agonist PX20606 ameliorates portal hypertension by targeting vascular remodelling and sinusoidal dysfunctionPhilipp Schwabl, Eva Hambruch, Berit A Seeland, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 17, 2026
Stage-specific drivers of clinical progression in advanced chronic liver diseaseBenedikt Simbrunner, Georg Semmler, Marta Bofill Roig, et al.
Clinical and Translational Gastroenterology|May 1, 2020
Altered Microbiota Diversity and Bile Acid Signaling in Cirrhotic and Noncirrhotic NASH-HCCSvenja Sydor, Jan Best, Insa Messerschmidt, et al.
Plos Medicine|November 16, 2012
Liver dysfunction and phosphatidylinositol-3-kinase signalling in early sepsis: experimental studies in rodent models of peritonitisPeter Recknagel, Falk A Gonnert, Martin Westermann, et al.
Pageof 78

Showing results (681-690 of 777) with videos related to

Sort By:
Pageof 78
Journal of Hepatology|May 23, 2017
norUrsodeoxycholic acid improves cholestasis in primary sclerosing cholangitisPeter Fickert, Gideon M Hirschfield, Gerald Denk, et al.
Diabetes|July 14, 2018
miR-30a Remodels Subcutaneous Adipose Tissue Inflammation to Improve Insulin Sensitivity in ObesityEun-Hee Koh, Natasha Chernis, Pradip K Saha, et al.
Ultraschall in Der Medizin (Stuttgart, Germany : 1980)|August 7, 2025
UDFF and Auto pSWE accurately assess liver steatosis and fibrosis risk in obese patients with MASLDNina Dominik, Larissa Nixdorf, Michael Schwarz, et al.
Gut|October 11, 2018
Inhibition of monoacylglycerol lipase, an anti-inflammatory and antifibrogenic strategy in the liverAida Habib, Dina Chokr, JingHong Wan, et al.
JHEP Reports : Innovation in Hepatology|June 17, 2025
Minimal residual ascites 3 months after TIPS implantation implicates worse clinical outcomes in patients with cirrhosisJim Benjamin Mauz, Lukas Hartl, Andrea Kornfehl, et al.
Journal of Autoimmunity|February 23, 2021
Histone deacetylase 1 controls CD4<sup>+</sup> T cell trafficking in autoinflammatory diseasesPatricia Hamminger, Luca Marchetti, Teresa Preglej, et al.
Journal of Hepatology|December 21, 2016
The FXR agonist PX20606 ameliorates portal hypertension by targeting vascular remodelling and sinusoidal dysfunctionPhilipp Schwabl, Eva Hambruch, Berit A Seeland, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 17, 2026
Stage-specific drivers of clinical progression in advanced chronic liver diseaseBenedikt Simbrunner, Georg Semmler, Marta Bofill Roig, et al.
Clinical and Translational Gastroenterology|May 1, 2020
Altered Microbiota Diversity and Bile Acid Signaling in Cirrhotic and Noncirrhotic NASH-HCCSvenja Sydor, Jan Best, Insa Messerschmidt, et al.
Plos Medicine|November 16, 2012
Liver dysfunction and phosphatidylinositol-3-kinase signalling in early sepsis: experimental studies in rodent models of peritonitisPeter Recknagel, Falk A Gonnert, Martin Westermann, et al.
Pageof 78